Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial

Clinical trial NCT00363168 · COMPLETED

Trial details

NCT number: NCT00363168
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Choroidal Neovascularization

Start date: 2006-08-01
Primary completion: 2008-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.